Want to track VIR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vir Biotechnology Inc. (VIR) Statistics
Valuation metrics
Market Cap 1.69B
Enterprise value 1.51B
Trailing P/E (ttm) -3.2
Forward P/E -
PEG ratio -0.1
Price/Sales (ttm) 25.83
Price/Book (mrq) 1.82
Enterprise Value/Revenue 23.07
Enterprise Value/EBITDA -3.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.02M
Average volume (90 days) 1.66M
Price summary
52-Week low 4.16
52-Week high 11.66
Beta -
50-Day moving average 8.96
200-Day moving average 8.32
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.76%
Operating margin -7.05%
Operational effectiveness
Return on assets -0.43%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.44
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 7.11%
Book value per share (mrq) 5.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
